» Articles » PMID: 35071141

Comparison and Analysis of Gut Microbiota in Children With IgA Vasculitis With Different Clinical Symptoms

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2022 Jan 24
PMID 35071141
Authors
Affiliations
Soon will be listed here.
Abstract

Henoch-Schönlein purpura, now called immunoglobulin A (IgA) vasculitis, is a common autoimmune disease in children, its association with gut microbiota composition remains unknown. The collected cases were divided into three groups: G1 group of simple skin type, G2 group with no digestive tract expression, G3 group of mixed digestive tract, and C group of healthy children. The fecal samples of each group of children were collected and the sequencing data was processed and analyzed. The dilution curve reflected the reasonableness of the amount of sequencing data. The number of species composition sequences in the G1, G2 and G3 groups was lower than that in the C group, especially for the G2 and G3 groups. The four most abundant bacteria were Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria. The relative abundance of Proteobacteria in the G2 and G3 groups was significantly higher than that in the G1 and C groups, while the relative abundance of Actinobacteria was significantly reduced, and the relative abundance of Actinobacteria in the G1 group was lower than that in the C group. Principal component analysis of the UPGMA clustering tree and each group of samples showed that the microbial community composition of the same group of samples was similar. The abundance of intestinal microbes in children with IgA vasculitis is lower than in normal children. Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria are the four most abundant bacteria in the intestinal flora of children. Proteobacteria and Actinobacteria are associated with organ involvement in IgA vasculitis.

Citing Articles

Analysis of gut microbiota variations in patients with Henoch-Schönlein purpura: a comprehensive systematic review.

Saad K, Abd-Ellatif M, Abdel-Hakem N, Ali A, Khalil O, Emad T Int Urol Nephrol. 2025; .

PMID: 39976893 DOI: 10.1007/s11255-025-04406-4.


Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota.

Li J, Xu Y, Sun T, Zhang X, Liang H, Lin W Front Immunol. 2024; 15:1430356.

PMID: 39717782 PMC: 11663840. DOI: 10.3389/fimmu.2024.1430356.


IgA Vasculitis (Henoch-Schönlein Purpura): An Update on Treatment.

Castaneda S, Quiroga-Colina P, Floranes P, Uriarte-Ecenarro M, Valero-Martinez C, Vicente-Rabaneda E J Clin Med. 2024; 13(21).

PMID: 39518760 PMC: 11546386. DOI: 10.3390/jcm13216621.


Large-scale bidirectional Mendelian randomization study identifies new gut microbiome significantly associated with immune thrombocytopenic purpura.

Li J, Li J, Liu Y, Zeng J, Liu Y, Wu Y Front Microbiol. 2024; 15:1423951.

PMID: 39027091 PMC: 11257036. DOI: 10.3389/fmicb.2024.1423951.


069 and 031: Unraveling Strain-Specific Pathways for Modulating Lipid Metabolism and Attenuating High-Fat-Diet-Induced Obesity in Mice.

Ho P, Chou Y, Koh Y, Lin W, Chen W, Tseng A ACS Omega. 2024; 9(26):28520-28533.

PMID: 38973907 PMC: 11223209. DOI: 10.1021/acsomega.4c02514.


References
1.
White J, Nagarajan N, Pop M . Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009; 5(4):e1000352. PMC: 2661018. DOI: 10.1371/journal.pcbi.1000352. View

2.
Geng H, Shu S, Dong J, Li H, Xu C, Han Y . Association study of gut flora in Wilson's disease through high-throughput sequencing. Medicine (Baltimore). 2018; 97(31):e11743. PMC: 6081054. DOI: 10.1097/MD.0000000000011743. View

3.
Boutin R, Sbihi H, DSouza M, Malhotra R, Petersen C, Dai D . Mining the infant gut microbiota for therapeutic targets against atopic disease. Allergy. 2020; 75(8):2065-2068. DOI: 10.1111/all.14244. View

4.
Tremlett H, Fadrosh D, Faruqi A, Hart J, Roalstad S, Graves J . Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol. 2016; 16(1):182. PMC: 5031272. DOI: 10.1186/s12883-016-0703-3. View

5.
Garza-Gonzalez E, Mendoza-Olazaran S, Morfin-Otero R, Ramirez-Fontes A, Rodriguez-Zulueta P, Flores-Trevino S . Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) FMT Enriched with in the Treatment of Recurrent Infection. Can J Gastroenterol Hepatol. 2020; 2019:4549298. PMC: 6955117. DOI: 10.1155/2019/4549298. View